Advanced Flower Capital (AFCG) is a publicly traded business development company that provides flexible credit, mainly senior secured loans, to lower middle-market businesses. For a BDC, quarterly results matter less for revenue growth and more for the durability of net investment income, the health of net asset value, and the quality of the loan portfolio. This report carries added weight because AFCG has been navigating a transition away from its legacy cannabis lending roots while contending with non-accrual loans and a slower private credit environment. Investors are watching closely to see whether a steadier balance sheet can translate into renewed origination activity and, eventually, higher recurring income. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
For the third quarter ended September 30, 2026, AFCG generated total investment income of $8.6 million and net investment income of $3.5 million, or $0.16 per weighted average share. The NII figure was roughly in line with consensus estimates and improved slightly from $0.15 per share in the second quarter. Total expenses came to $5.0 million, down from $5.2 million in the prior quarter, helped in part by a management fee rebate of about $176,000.
The headline "net increase in net assets resulting from operations" was $6.4 million, or $0.28 per share, compared with $5.4 million, or $0.23 per share, in the second quarter. Much of that upside stemmed from $2.9 million, or $0.13 per share, of net unrealized appreciation on investments, not from new earnings power. NAV per share increased to $8.55 at September 30, 2026, up $0.30 from June 30, reflecting net investment income, unrealized appreciation, and roughly $0.06 per share of accretion from share repurchases completed below NAV, partially offset by the $0.05 quarterly distribution.
On the balance sheet, total assets were $395.1 million and net assets were $191.6 million. The portfolio was valued at $289.6 million across 18 investments, all senior secured first lien debt. Debt-to-equity improved to 1.03x from 1.10x, and the asset coverage ratio rose to 197%. The company paid its $0.05 per share third-quarter distribution on October 15, 2026.
Heading into the report, attention centered on whether AFCG's improving NAV could be matched by stronger recurring income. The results delivered a mixed picture that investors appeared to weigh carefully. NII of $0.16 per share held up against expectations, and the continued climb in NAV per share signaled a healing balance sheet. However, total investment income declined again, and gross fundings of just $4.6 million underscored how slow new deployment has become.
Sentiment also reflected lingering caution around legacy credit issues. Management noted that the Justice Grown loan remains in maturity default, with Article 9 collateral dispositions scheduled for November, and that recoveries on non-accrual positions remain uncertain. The combination of steady earnings, a stronger book value, and slower growth left the stock's near-term reaction dependent on how investors balance balance-sheet progress against a still-quiet lending engine.
Looking ahead, the key question for AFCG is whether capital deployment can reaccelerate. Management described the pipeline at approximately $1.1 billion but cautioned that deal flow is likely to be "choppy" and "lumpy" over the next few quarters. A $43 million senior secured facility to a sponsor-backed healthcare services platform, agented by its affiliated TCG platform, is expected to close in the near term and could mark a step toward more consistent origination.
Investors should also monitor the resolution of non-accrual and defaulted positions. The outcome of the Justice Grown collateral dispositions and ongoing recoveries tied to the Devvy receivership will influence both realized gains and future NAV. Post-quarter, AFCG sold its Trulieve senior notes for a roughly $2 million realized gain and repurchased $19 million of its 2027 notes at a discount, booking an additional gain while reducing upcoming debt obligations.
Finally, watch the trajectory of leverage and distributions. With roughly $102 million in cash at quarter end and a comfortable asset coverage ratio of 197%, the company has capacity to deploy once suitable deals materialize. The board typically reviews the dividend in December, and its capital-allocation decisions will signal management's confidence in the durability of recurring income versus the current discount between the share price and NAV.
I often turn to Tickeron’s AI Screener when reviewing names like this one. The platform lets me apply filters for technical patterns, fundamentals, and AI-driven signals across thousands of securities, helping surface comparable setups and monitor sentiment shifts more efficiently than manual reviews. It has become a regular part of how I cross-check portfolio health and origination trends in the BDC space.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
AFCG saw its Momentum Indicator move above the 0 level on November 03, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 90 similar instances where the indicator turned positive. In 63 of the 90 cases, the stock moved higher in the following days. The odds of a move higher are at 70%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AFCG's RSI Indicator exited the oversold zone, 21 of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 64%.
The Moving Average Convergence Divergence (MACD) for AFCG just turned positive on October 30, 2026. Looking at past instances where AFCG's MACD turned positive, the stock continued to rise in 33 of 50 cases over the following month. The odds of a continued upward trend are 66%.
Following a +6.69% 3-day Advance, the price is estimated to grow further. Considering data from situations where AFCG advanced for three days, in 168 of 270 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
AFCG moved below its 50-day moving average on October 07, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for AFCG crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 65%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AFCG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
AFCG broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AFCG entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 26 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. AFCG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 73 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.359) is normal, around the industry mean (2.440). P/E Ratio (15.737) is within average values for comparable stocks, (-3.350). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.319). Dividend Yield (0.067) settles around the average of (0.267) among similar stocks. P/S Ratio (3.212) is also within normal values, averaging (15.694).
The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AFCG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InvestmentManagers